Messerschmidt Addresses the Future of Cancer Vaccines in FiercePharma

Precision Oncology’s Gerry Messerschmidt, MD, talks with FiercePharma’s Eric Sagonowsky and predicts we’ll see licensed cancer vaccines in the next 2 to 3 years.

To read the complete article, please click here.